Am. Lafont et al., EFFECT OF ALPHA-TOCOPHEROL ON RESTENOSIS AFTER ANGIOPLASTY IN A MODELOF EXPERIMENTAL ATHEROSCLEROSIS, The Journal of clinical investigation, 95(3), 1995, pp. 1018-1025
The ability of alpha-tocopherol to reduce restenosis after angioplasty
was tested in a rabbit model in which angioplasty was performed on es
tablished atherosclerotic lesions. Lesions induced by 4 wk of choleste
rol feeding after focal desiccation of femoral arteries were balloon d
ilated. 3 wk after angioplasty, angiographically determined minimum lu
minal diameters were less in the untreated group (0.80+/-0.51 mm) than
in the group treated with oral alpha-tocopherol beginning 19 d before
angioplasty (1.38+/-0.29 mm; P < 0.01). The cross-sectional area of t
he intima-media was greater in the untreated group (1.18+/-0.48 mm(2))
than in the alpha-tocopherol group (0.62+/-0.25 mm(2), P < 0.0001). T
hese differences were not due to vasoconstriction or altered plasma ch
olesterol. Alpha-tocopherol thus reduced restenosis after angioplasty
in this model. In rabbit vascular smooth muscle cells, oxidized low de
nsity lipoprotein stimulated DNA synthesis. Alpha-tocopherol treatment
inhibited DNA synthesis stimulated by oxidized low density lipoprotei
n, but not by serum. The findings are consistent with the hypothesis t
hat oxidized lipids can stimulate hyperplasia and that antioxidants ma
y limit hyperplasia by inhibiting either the oxidation or the prolifer
ative effects of oxidants on cells.